Related Experiment Video
Updated: Jul 10, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Kidney disease in Bahrain: a biopsy based epidemiologic study
Ahmed Al Arrayed1, Shameem Shariff, Majeda Musabah Al Maamari
1Department of Nephrology, Salmaniya Medical Complex, Bahrain.
This study analyzed 145 renal biopsies in Bahrain from 2003-2006, finding glomerular diseases were most common. The incidence of renal biopsies was 5.4 per 100,000 annually.
Area of Science:
- Nephrology
- Renal Pathology
Background:
- Renal diseases pose a significant health burden globally.
- Understanding the local epidemiology of kidney diseases is crucial for public health planning.
Purpose of the Study:
- To determine the incidence and patterns of biopsy-proven renal diseases in Bahrain.
- To analyze the types and prevalence of glomerular and non-glomerular kidney diseases.
Main Methods:
- Retrospective analysis of 145 renal biopsies from 130 patients.
- Data collected between January 2003 and October 2006.
- Categorization of biopsies into glomerular diseases, allografts, chronic glomerulosclerosis, and others.
Main Results:
- Glomerular diseases accounted for 64.8% of biopsies, followed by renal allografts (23.4%).
- The incidence of renal biopsies was 5.4 per 100,000 population per year.
- Minimal change disease-focal segmental glomerulosclerosis (MCD-FSGS) complex was the most frequent primary glomerular disease; lupus nephritis was the most common secondary glomerulopathy.
Conclusions:
- Glomerular diseases are the predominant indication for renal biopsies in Bahrain.
- The pattern of glomerulonephritis has remained consistent with previous reports.
- Lupus nephritis and MCD-FSGS complex are key diagnoses in the Bahraini population requiring kidney biopsy.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Kidney Transplant I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
